Health Catalyst, Inc.
HCAT· Nasdaq
Released Nov 12, 2019, after the close
10-Q filed Nov 13, 2019, 44 days after period end · 0001636422-19-000027
| Metric | Q3 2019 | Q3 2018 |
|---|---|---|
| Revenue | $39.42M | $32.87M |
| Net Income | -$21.42M | -$16.88M |
| EPS Diluted | -$1.40 | -$3.71 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2019 · filed Nov 13, 2019 · 44 d after period end
+5.4% from the close of Nov 12, 2019 to the close of Nov 13, 2019, the first after the release.